Evidence map›Paper›PMID 41915143›Full record

ArticleProbiotics and antimicrobial proteins2026

Design of AMPs Targeting BamA as a Potential Target and Research on Their Antimicrobial Mechanisms.

Hongyou Chen, Xu Zou, Peiqi Peng, Mingtao Peng, Haoran Liang, Minghe Luo, Tao Wang, Ning Zhang, Qing Zhang, Yuanqiang Wang

Abstract read
PubMed Publisher
In one paragraph

Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hongyou Chen *Chongqing Key Laboratory of Targeted Drug Screening and Activity Evaluation of Higher Education Institutions, School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, 400054, China.
Xu Zou *Chongqing Key Laboratory of Targeted Drug Screening and Activity Evaluation of Higher Education Institutions, School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, 400054, China.
Peiqi Peng *Chongqing Key Laboratory of Targeted Drug Screening and Activity Evaluation of Higher Education Institutions, School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, 400054, China.
Mingtao Peng *Chongqing Key Laboratory of Targeted Drug Screening and Activity Evaluation of Higher Education Institutions, School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, 400054, China.
Haoran LiangChongqing Key Laboratory of Targeted Drug Screening and Activity Evaluation of Higher Education Institutions, School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, 400054, China.
Minghe LuoChongqing Key Laboratory of Targeted Drug Screening and Activity Evaluation of Higher Education Institutions, School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, 400054, China.
Tao WangChongqing Key Laboratory of Targeted Drug Screening and Activity Evaluation of Higher Education Institutions, School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, 400054, China.
Ning ZhangChongqing Key Laboratory of Targeted Drug Screening and Activity Evaluation of Higher Education Institutions, School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, 400054, China. zhangning88@cqut.edu.cn.
Qing ZhangInstitute of Burn Research, State Key Laboratory of Trauma and Chemical Poisoning, Chongqing Key Laboratory for Disease Proteomics, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, 400038, China. zhangqing1989109@163.com.
Yuanqiang WangChongqing Key Laboratory of Targeted Drug Screening and Activity Evaluation of Higher Education Institutions, School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, 400054, China. wangyqnn@cqut.edu.cn.

Funding

Major Project of Science and Technology Research Program of Chongqing Education Commission of China KJQN202301118, KJZD-M202401102National Natural Science Foundation of China 82202448
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Activity evaluation and mechanism researchAntimicrobial peptideDrug molecule designDrug-resistant bacteriaTargeting the BamA protein

Identifiers

PMID41915143

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.